We are live on ! Find out more
OGC

One68 Global Capital Portfolio holdings

AUM $30.9M
This Fund
S&P 500
This Quarter Est. Return
+29.58%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$49.8M
AUM Growth
+$12.1M
Cap. Flow
+$9.46M
Cap. Flow %
18.99%
Top 10 Hldgs %
44.63%
Holding
139
New
99
Increased
4
Reduced
13
Closed
20

Sector Composition

Rank Sector Weight
1 Technology 28.7%
2 Healthcare 23.76%
3 Financials 15.51%
4 Communication Services 5.92%
5 Consumer Discretionary 5.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGHC
1
DELISTED
National General Holdings Corp
NGHC
$4.48M 8.99%
+131,000
New +$4.46M
WORK
2
DELISTED
Slack Technologies, Inc.
WORK
$4.06M 8.14%
+96,020
New +$3.24M
ACIA
3
DELISTED
Acacia Communications Inc
ACIA
$2.88M 5.78%
39,479
-79,754
-67% -$5.51M
VRTU
4
DELISTED
Virtusa Corporation
VRTU
$2.36M 4.73%
46,092
+15,773
+52% +$792K
INFO
5
DELISTED
IHS Markit Ltd. Common Shares
INFO
$1.8M 3.61%
+20,000
New +$1.73M
ALXN
6
DELISTED
Alexion Pharmaceuticals
ALXN
$1.57M 3.15%
+10,049
New +$1.29M
DD icon
7
DuPont de Nemours
DD
$18.5B
$1.42M 2.85%
+15,933
New +$1.25M
GRWG icon
8
GrowGeneration
GRWG
$86.5M
$1.41M 2.84%
35,133
-42,422
-55% -$1.14M
ADI icon
9
Analog Devices
ADI
$179B
$1.21M 2.43%
+8,190
New +$1.09M
BMY icon
10
Bristol-Myers Squibb
BMY
$133B
$1.05M 2.12%
+17,000
New +$1.05M
LCAPU
11
DELISTED
Lionheart Acquisition Corp. II Unit
LCAPU
$1.01M 2.03%
97,300
-52,700
-35% -$534K
T icon
12
AT&T
T
$159B
$1.01M 2.02%
46,340
+33,100
+250% +$714K
PFE icon
13
Pfizer
PFE
$143B
$920K 1.85%
25,000
+9,190
+58% +$337K
CAH icon
14
Cardinal Health
CAH
$53.9B
$803K 1.61%
+15,000
New +$778K
INTC icon
15
Intel
INTC
$455B
$775K 1.56%
+15,701
New +$767K
MRVL icon
16
Marvell Technology
MRVL
$168B
$713K 1.43%
+15,000
New +$649K
VAR
17
DELISTED
Varian Medical Systems, Inc.
VAR
$705K 1.41%
+4,028
New +$698K
CLCT
18
DELISTED
Collectors Universe
CLCT
$615K 1.23%
+8,150
New +$553K
RP
19
DELISTED
RealPage, Inc.
RP
$611K 1.23%
+7,000
New +$459K
NVO
20
Novo Nordisk
NVO
$208B
$588K 1.18%
+16,830
New +$582K
UVXY icon
21
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$224M
$575K 1.15%
22
-3
-12% -$109K
JOBS
22
DELISTED
51job Inc
JOBS
$574K 1.15%
+8,207
New +$593K
MRNA icon
23
Moderna
MRNA
$21.8B
$522K 1.05%
+5,000
New +$506K
CELU icon
24
Celularity
CELU
$18.4M
$520K 1.04%
4,726
-3,329
-41% -$354K
MLACU
25
DELISTED
Malacca Straits Acquisition Company Limited Units
MLACU
$514K 1.03%
+50,000
New +$504K

Similar funds

One68 Global Capital's Q4 2020 Portfolio in Review

As of Q4 2020, One68 Global Capital held 139 positions worth $49.8M, up 32% from $37.7M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

One68 Global Capital deployed $9.46M of net new capital in Q4 2020, opening 99 new positions and adding to 4 existing holdings. Its largest new stake was National General Holdings Corp: 131,000 shares worth $4.48M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Acacia Communications Inc, an estimated $5.51M trimmed.

  • One68 Global Capital's largest Q4 2020 buy was National General Holdings Corp: 131,000 shares worth $4.48M.
  • One68 Global Capital added most to Virtusa Corporation in Q4 2020, an estimated $792K increase.
  • One68 Global Capital's biggest Q4 2020 reduction was Acacia Communications Inc, cutting an estimated $5.51M.
  • One68 Global Capital fully exited Immunomedics Inc in Q4 2020, selling an estimated $5.19M.
  • One68 Global Capital's ten largest holdings make up 45% of its $49.8M portfolio in Q4 2020.
  • One68 Global Capital opened 99 new positions and closed 20 in Q4 2020.
  • One68 Global Capital's portfolio value rose 32% quarter-over-quarter to $49.8M.

Based on One68 Global Capital's 13F filing for Q4 2020, filed 16 Feb 2021.